Rituximab for the treatment of follicular lymphoma

This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta110

Important information about this guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 243.